| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $404.1M | -3.4% |
| Cost of Revenue | $24.0M | +0.1% |
| R&D Expense | $31.7M | -11.2% |
| SG&A Expense | $28.1M | +13.8% |
| Operating Income | -$24.8M | -13.1% |
| Pre-tax Income | -$24.4M | -11.3% |
| Income Tax | -$2.5M | +0.0% |
| Net Income | -$24.4M | -25.6% |
| EPS (Basic) | -$0.77 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.8M | -11.5% |
| Accounts Receivable | $29.6M | -17.0% |
| Current Assets | $81.0M | -4.4% |
| Total Assets | $156.5M | +9.0% |
| Current Liabilities | $45.4M | -4.2% |
| Total Liabilities | $49.0M | -16.2% |
| Stockholders' Equity | $107.5M | +26.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.8M | -319.7% |
| Investing Cash Flow | -$4.3M | +77.2% |
| Financing Cash Flow | $15.8M | +338.2% |
| -14.9% |
| EPS (Diluted) | -$0.77 | -14.9% |